SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (3973)4/2/1998 1:40:00 AM
From: billkirn  Read Replies (1) of 6136
 
Steve: Remember, the lack of Roche R&D contribution will start affecting earnings now. We need to reduce our earnings expectations over the next 6 months or so. I wouldn't be surprised if earnings will disappoint expectations over the next few quarters, maybe not this one.
What will drive this great company will be the next drug, let's hope ag3340 exceeds expectations. Some people think it will.
Bill

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News